Cowen Remains Bullish on Ironwood Pharma (IRWD) Following 1Q

May 8, 2017 4:24 PM

Cowen reiterated an Outperform rating and $20.00 price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) following the company's 1Q earnings report ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found